TOPIC 453: A DIGITAL TOOL TO INTEGRATE CANCER PREVENTION WITHIN PRIMARY CARE Moonshot support

主题 453：将癌症预防纳入初级保健的数字工具 Moonshot 支持

• 批准号: 10929760
• 负责人: GRACE CHEN
• 金额: $ 39.3万
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-31 至 2024-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10929760
• 关键词: Address; American; American Cancer Society; Architecture; Area; Assessment tool; Back; Behavior Therapy; Cancer Center; Cancer Patient; Caring; Categories; Certification; Chicago; Client; Clinic; Clinical; Clinical Management; Code; Communication; Communities; Complement; Complex; Computer software; Consensus; Consent Forms; Consult; Contracts; Data; Data Collection; Data Element; Data Reporting; Databases; Development; Devices; Diet; Education; Eligibility Determination; Ensure; Environment; Environmental Risk Factor; Epidemiology; Family; Family Cancer History; Fast Healthcare Interoperability Resources; Feedback; Funding; General Population; Genetic; Guidelines; Health; Health Insurance Portability and Accountability Act; Health Personnel; Health Technology; Health system; Healthcare; Healthcare Systems; Home; Hospitalization; Hypertension; Infrastructure; Institution; Insurance Carriers; Intelligence; Language; Laws; Life Style; Location; Malignant Neoplasms; Managed Care; Medical; Medical Care Team; Medical Device; Medical center; Monitor; National Comprehensive Cancer Network; Notification; Nurses; Obesity; Oncologist; Patient Care; Patient Self-Report; Patient risk; Patients; Persons; Phase; Physicians; Population; Prevention Guidelines; Prevention program; Preventive; Primary Care; Primary Care Physician; Privacy; Process; Production; Protocols documentation; Provider; Publishing; Recommendation; Recording of previous events; Reporting; Research; Research Personnel; Review Literature; Risk; Risk Assessment; Risk Factors; Running; Sampling; San Francisco; Schedule; Science; Secure; Security; Services; Stream; Surveys; Talents; Telemedicine; Testing; Tobacco use; United States Preventative Services Task Force; Update; Vaccines; Visit; Work; anticancer research; cancer diagnosis; cancer prevention; cancer risk; cancer type; care providers; cloud based; cost effective; data exchange; data integration; data management; design; digital health; digital healthcare; digital platform; digital tool; encryption; experience; feasibility testing; firewall; flexibility; genetic testing; health care service organization; high risk; indexing; individual patient; innovation; interest; malignant breast neoplasm; medical specialties; patient engagement; patient expectation; patient health information; patient navigation; primary care practice; primary care provider; privacy protection; programs; recruit; remote health care; remote patient monitoring; repository; risk prediction; risk stratification; routine screening; rural area; satisfaction; screening; service organization; software development; supplemental screening; systematic review; telehealth; tool; usability; user-friendly; web services

LucidAct Inc. (LucidAct) is a Digital Health company that offers connected telemedicine and Remote Patient Monitoring (RPM) solutions specifically designed for patients that are non-tech savvy, living in rural areas, or having cultural and/or language barriers. We provide an end-to-end remote care management solution that combines connected medical devices, telehealth, and intelligent patient engagement into a single solution for healthcare organizations. LucidAct platform is cost effective, responsive, and user-friendly for all end-users, including patients, nurses, and physicians. Under this NCI contract, LucidAct will develop a digital tool for cancer prevention, in which we will identify patients that are at high-risk by assessing all potential risk factors including family history, genetics, and environmental factors (tobacco use, diet, obesity, etc.). We will offer science- and guideline-based recommendations to patients to engage in lifestyle changes to reduce cancer risk. LucidAct’s innovative workflow engine is customizable and configurable to manage complex care and to personalize recommendations to each individual patient. We have a team of healthcare and technology professionals that integrate expertise and healthcare data with PCP care and patient expectations to implement smart and usable solutions to complement and extend patient engagement beyond in-person visits.

Lucidact Inc.（Lucidact）是一家数字保健公司，提供连接的远程医疗和远程患者监控（RPM）解决方案，专门为精通非技术的患者设计，居住在农村地区或具有文化和/或语言障碍的患者。我们提供了一种端到端的远程护理管理解决方案，该解决方案将互联的医疗设备，远程医疗和智能的患者参与结合到医疗组织的单一解决方案。 Lucidact平台对所有人都具有成本效益，响应式和用户友好 最终用户，包括患者，护士和医生。根据该NCI合同，Lucidact将开发一种用于预防癌症的数字工具，在该工具中，我们将通过评估所有潜在的风险因素（包括家族史，遗传学和环境因素（烟草使用，饮食，饮食，肥胖等））来确定处于高风险的患者。我们将向患者提供基于科学和指南的建议，以减少癌症风险。 Lucidact的创新工作流引擎可自定义且可配置，可管理复杂的护理并为每个患者提供个性化建议。我们有一个由医疗保健和技术专业人员组成的团队，将专业知识和医疗保健数据与PCP护理以及患者期望整合在一起，以实施智能和可用的解决方案，以完成和扩展患者的参与度超出面对面的访问。